Recalls / Active ingredient / Orphenadrine Citrate
Orphenadrine Citrate
2 FDA drug recalls involving the active ingredient “Orphenadrine Citrate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2022-03-21 | Class II | Orphenadrine Citrate Extended-Release Tablets, USP 100 mg, Rx Only, 100 Tablets, Manufactured by Sandoz Inc., | Sandoz, Inc |
| 2014-07-11 | Class III | Orphenadrine Citrate Extended Release Tablets, 100 mg a)100-count bottle, (NDC 0185-0022-01) b) 1000-count b | Sandoz Inc |